Atenolol for prevention of postsurgical cardiovascular events.
Shapley-Quinn
K
K
University of North Carolina at Chapel Hill, USA.
Newton
W
W
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000368:Aged; D001262:Atenolol / Q000627:therapeutic use*; D004311:Double-Blind Method; D017558:Elective Surgical Procedures; D006331:Heart Diseases / Q000517:prevention & control*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control*; D011292:Premedication; D015203:Reproducibility of Results; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D001262:Atenolol